| Return Create A Forum - Home | |
| --------------------------------------------------------- | |
| MS Speaks | |
| https://msspeaks.createaforum.com | |
| --------------------------------------------------------- | |
| ***************************************************** | |
| Return to: OCREVUS (ocrelizumab) | |
| ***************************************************** | |
| #Post#: 4638-------------------------------------------------- | |
| Ocrevus biosimilar (Xacrel) shows equivalent efficacy as MS trea | |
| tment | |
| By: agate Date: December 3, 2024, 12:43 am | |
| --------------------------------------------------------- | |
| From the American Journal of Managed Care/Center for Biosimilars | |
| (November 26, 2024) | |
| "[Ocrelizumab] biosimilar shows equivalent efficacy as multiple | |
| sclerosis treatment": | |
| https://bit.ly/49ne1QO | |
| ***************************************************** |